Skip to content

Elaine Schattner

writer, health care advocate, physician

  • about
  • academic
  • journalist
  • patient advocate
  • portfolio
  • contact

clinical trials

Is There A Better Place To Decide What’s Right For Patients?

Is There A Better Place To Decide What’s Right For Patients?

Dr. Robert Califf Shares Ideas About Real-World Evidence And Health Data

Dr. Robert Califf Shares Ideas About Real-World Evidence And Health Data

A PARP Inhibitor Keeps Some Cancers In Check For Years

A PARP Inhibitor Keeps Some Cancers In Check For Years

A New Antibody For Treating Acute Lymphocytic Leukemia?

A New Antibody For Treating Acute Lymphocytic Leukemia?

Encouraging Results For Ribociclib In Advanced Breast Cancer

Encouraging Results For Ribociclib In Advanced Breast Cancer

Tragedy In A Clinical Trial: A Reminder That Biotech Is Not A Game

Tragedy In A Clinical Trial: A Reminder That Biotech Is Not A Game

A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer

A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer

Report Touts Benefits Of Prolonged Medication After Breast Cancer. Is It Persuasive?

Report Touts Benefits Of Prolonged Medication After Breast Cancer. Is It Persuasive?

The Emerging Value Of Personalized Phase 1 Clinical Trials In Oncology with permission, Maria Schwaederle, PharmD

The Emerging Value Of Personalized Phase 1 Clinical Trials In Oncology

The Big News For Sickle Cell Anemia Is Not Gene Therapy

The Big News For Sickle Cell Anemia Is Not Gene Therapy

In A First, Kidney Cancer Drug Extends Survival

In A First, Kidney Cancer Drug Extends Survival

Why Evidence From A Clinical Trial Of Ovarian Cancer Has Limited Value

Why Evidence From A Clinical Trial Of Ovarian Cancer Has Limited Value

In Lumpectomy For Breast Cancer, Taking Out A Bit More Reduces O.R. Revisits

In Lumpectomy For Breast Cancer, Taking Out A Bit More Reduces O.R. Revisits

What’s Intriguing And Concerning About Early Results For Keytruda In Breast Cancer

What’s Intriguing And Concerning About Early Results For Keytruda In Breast Cancer

Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer

Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer

What’s Missing in the Recent Mammography Value Study

What’s Missing in the Recent Mammography Value Study

  • clips
  • breast cancer
  • breast cancer screening
  • precision oncology
  • survivorship
  • being a patient
  • being a doctor
  • health care policy
  • notes on TV, movies, plays, books, music…
Proudly powered by WordPress | Theme: Sketch by WordPress.com.